BONYF NV bonyf NV: bonyf's 2023 financial statements made available
Transparency directive : regulatory news
28/06/2024 17:12
bonyf NV
/ Key word(s): Annual Results
bonyf NV: bonyf's 2023 financial statements made available
28-Jun-2024 / 17:12 CET/CEST
bonyf NV: bonyf’s 2023 financial statements made available
|
![fncls.ssp?fn=download2_file&code_str=3012e93bdb302306bf3501c203b740f5](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=3012e93bdb302306bf3501c203b740f5)
|
Knokke (Belgium), 28 June 2024, 4:00 p.m; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products, presents its 2023 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.
|
Statements are available on request.
|
bonyf’s strengths
- Products with patented formulations
- Produced in Switzerland compliant with stringent international quality regulations
- Proven clinical efficacy
- Commercial presence in 37 countries
- Prospects for solid growth and rapid profitability
- A fast-growing oral and dental care market
|
![fncls.ssp?fn=download2_file&code_str=c64b549ac62c5c1fd4e2d85cb45f27b8](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=c64b549ac62c5c1fd4e2d85cb45f27b8)
|
About bonyf
Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market.
For more information about bonyf and its innovative oral care products, please visit www.bonyf.com.
|
bonyf
Jean-Pierre Bogaert
investor@bonyf.com
|
![fncls.ssp?fn=download2_file&code_str=f37a5d0d7e425d905a363ed1cb3eed54](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=f37a5d0d7e425d905a363ed1cb3eed54)
Dissemination of a Financial Wire News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
|
Language: |
English |
Issuer: |
bonyf NV |
|
Doornzelestraat 114 D |
|
9000 Gent |
|
Belgium |
Phone: |
+41 79 412 42 79 |
E-mail: |
president@bonyf.com |
Internet: |
www.bonyf.com |
ISIN: |
BE6333353298 |
EQS News ID: |
1936093 |
|
End of Announcement - EQS News Service |
|
1936093 28-Jun-2024 CET/CEST
source : webdisclosure.com